UNSPSC 51112305: Mannosulfan

This classification denotes an alkylsulfonate compound with the molecular formula C10H22O14S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 135FQ40L36, chemically known as 1,2,5,6-tetramethanesulphonyl-d-mannite but more generally known as mannosulfan, which bears US NIH Compound Identifier 24140. European Medicines Agency schedules Mannosulfan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08644MIG.

UNSPSC 51112305 Mannosulfan is a Commodity code tracking a specific pharmaceutical active ingredient used in prescription medications; state and local governments purchase this product primarily through pharmacy benefit programs and state health agency procurement channels. The Texas Health and Human Services Commission issued a Request for Information (RFI) on March 27, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative (TPI) Direct-to-Manufacturer Prescriptions program, signaling state interest in direct pharmaceutical supply relationships outside traditional pharmacy benefit manager, group purchasing organization, and wholesaler channels. The scope under this code involves state health agencies and pharmacy benefit programs sourcing active pharmaceutical ingredients and finished medications to support employee health plans, retiree programs, and Medicaid populations; the TPI initiative specifically targets direct contracting models with negotiated net pricing and outcomes-based agreements to improve cost management and fulfillment efficiency.

Issuing bodies under this code center on state health and human services departments managing pharmacy benefits for state employees and covered populations. The Texas Health and Human Services Commission represents the primary recent buyer identified, with its March 27, 2026 RFI closing April 3, 2026. The RFI stage indicates the state is still gathering market intelligence on vendor capabilities for direct-to-manufacturer contracting rather than issuing a formal RFP with budget or timeline commitments; subsequent formal solicitations will likely follow once the state develops detailed procurement specifications and pricing models based on vendor responses. No geographic spread across multiple states is evident from the available opportunities, with Texas HHS Commission activity being the sole documented recent procurement signal under this code.